Successful treatment with dabrafenib (GSK2118436) in a patient with ganglioglioma

J Clin Oncol. 2014 Oct 10;32(29):e98-e100. doi: 10.1200/JCO.2013.48.6852. Epub 2014 Feb 10.

Authors

Kent C Shih¹, Mythili Shastry², Jeffrey T Williams³, Peter F Jelsma³, Steven R Abram³, Kanyalakshmi Ayyanar⁴, Howard A Burris 3rd⁵, Jeffrey R Infante⁵

Affiliations

¹ Sarah Cannon Research Institute; Tennessee Oncology; and St Thomas Hospital, Nashville, TN [email protected].
² Sarah Cannon Research Institute, Nashville, TN.
³ St Thomas Hospital, Nashville, TN.
⁴ Kosair Children's Hospital, University of Louisville, Louisville, KY.
⁵ Sarah Cannon Research Institute; and Tennessee Oncology, Nashville, TN.

PMID: 24516030
DOI: 10.1200/JCO.2013.48.6852

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / therapeutic use*
Brain Neoplasms / drug therapy*
Brain Neoplasms / pathology
Ganglioglioma / drug therapy*
Ganglioglioma / pathology
Humans
Imidazoles / therapeutic use*
Magnetic Resonance Imaging
Male
Oximes / therapeutic use*
Young Adult

Substances

Antineoplastic Agents
Imidazoles
Oximes
dabrafenib